The final, formatted version of the article will be published soon.
CASE REPORT article
Front. Oncol.
Sec. Surgical Oncology
Volume 15 - 2025 |
doi: 10.3389/fonc.2025.1442233
Hepatic Epithelioid hemangioendothelioma with TFE3 rearrangement: a case report and literature review
Provisionally accepted- The Second Affiliated Hospital of Dalian Medical University, Dalian, China, Dalian, China
Epithelioid hemangioendothelioma (EHE) is a rare low-grade malignant tumor of vascular origin. It may be confusing as its manifestations of multifocal lesions on imaging and epithelial histomorphology in pathology. EHE is easy to be mistaken for a metastatic tumor by radiologists and clinicians. Correct diagnosis and therapy are important owing to the variable clinical course and special treatment. EHEs harbor major CAMTA1 rearrangement and <5% TFE3 rearrangement.Meanwhile, EHE with TFE3 rearrangement has distinctive morphology features. Currently, there are only two cases of hepatic EHE with TFE3 rearrangement reported, we present another case here that occurred in a 34-year-old female. Both the clinician and radiologist provisionally considered it as a metastatic tumor. The tumor cells have mild atypia but infiltrative growth patterns like benign vascular tumors. Our case is unique mainly in that the absence of its characteristic well-defined vessels, and the presence of unreported morphology of intraluminal papillary proliferation of tombstone or hobnail endothelial cells. The final diagnosis of EHE with TFE3 rearrangement was made by combining morphological, immunohistochemical, and molecular test results. The patient did not receive any treatment according to her condition and no change was detected in the mass's size and number on CT images during 3.5 years of follow-up.
Keywords: Epithelioid hemangioendothelioma, TFE3 rearrangement, Liver, Imaging features, case report
Received: 01 Jun 2024; Accepted: 03 Jan 2025.
Copyright: © 2025 Meng, Xingrong, Guo and Tao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Sitong Guo, The Second Affiliated Hospital of Dalian Medical University, Dalian, China, Dalian, China
Juan Tao, The Second Affiliated Hospital of Dalian Medical University, Dalian, China, Dalian, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.